Talphera (TLPH) Operating Margin Growth (1y) (2015 - 2022)
Powered by 
Analysis
Talphera (TLPH) Operating Margin Growth (1y) (2015 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 602.00 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -16,814.00 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -143.00 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 78.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1,135.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 7,666.00 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2,002.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -2,881.00 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -1.23 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -24,603.00 |
| Dec 31, 2021 | -40.75 Mn |
| Sep 30, 2021 | 19,696.00 |
| Jun 30, 2021 | -202,700.00 |
| Mar 31, 2021 | 231,666.00 |
| Dec 31, 2020 | 190,364.00 |
| Sep 30, 2020 | 156,539.00 |
| Jun 30, 2020 | 118,615.00 |
| Mar 31, 2020 | 54,260.00 |
| Dec 31, 2019 | -136,551.00 |
| Sep 30, 2019 | 24,828.00 |
| Jun 30, 2019 | -54,542.00 |
| Mar 31, 2019 | -223,751.00 |
| Dec 31, 2018 | -73,570.00 |
| Sep 30, 2018 | -187,837.00 |
| Jun 30, 2018 | -50,059.00 |
| Mar 31, 2018 | -202,246.00 |
| Dec 31, 2017 | -94,408.00 |
| Sep 30, 2017 | -35,897.00 |
| Jun 30, 2017 | -19,019.00 |